key: cord-0879052-4y74y49r authors: Abdelhamid, Leila; Luo, Xin M. title: Diet and Hygiene in Modulating Autoimmunity During the Pandemic Era date: 2022-01-05 journal: Front Immunol DOI: 10.3389/fimmu.2021.749774 sha: 51767dec0aa4c3678300ec9e3847604c0a16345d doc_id: 879052 cord_uid: 4y74y49r The immune system is an efficiently toned machinery that discriminates between friends and foes for achieving both host defense and homeostasis. Deviation of immune recognition from foreign to self and/or long-lasting inflammatory responses results in the breakdown of tolerance. Meanwhile, educating the immune system and developing immunological memory are crucial for mounting defensive immune responses while protecting against autoimmunity. Still to elucidate is how diverse environmental factors could shape autoimmunity. The emergence of a world pandemic such as SARS-CoV-2 (COVID-19) not only threatens the more vulnerable individuals including those with autoimmune conditions but also promotes an unprecedented shift in people’s dietary approaches while urging for extraordinary hygiene measures that likely contribute to the development or exacerbation of autoimmunity. Thus, there is an urgent need to understand how environmental factors modulate systemic autoimmunity to better mitigate the incidence and or severity of COVID-19 among the more vulnerable populations. Here, we discuss the effects of diet (macronutrients and micronutrients) and hygiene (the use of disinfectants) on autoimmunity with a focus on systemic lupus erythematosus. The immune system is highly toned and efficiently dedicated to maintaining health by protecting against a tremendous array of invaders (1) . Our body faces continuous challenges that might be represented in biological threats (such as, but not limited to, microbial pathogens) and physical threats (such as radiation and chemicals). The immune system is equipped with both innate and adaptive arms to fight against these threats (1) . The ultimate goal of our immune system is to induce an effective and balanced inflammatory response that enables the efficient elimination of possible threats without causing excessive collateral tissue damage (2) . Therefore, an optimal immune response includes recognition, mounting an overarching reaction, then returning to normal homeostasis without skewing to either immunodeficiency or autoimmunity (3, 4) . It is fascinating how this system discriminates between friends and foes to maintain homeostasis (5) . Innate defenses are inborn abilities of the immune system to detect, attack, and eliminate (or at least restrain) pathogenic invaders. Part of the body's defense system that includes physical barriers (6) , antimicrobial peptides (7) , and complement proteins (8) , innate immune cells are equipped with germline-encoded sensors called pattern recognition receptors (PRRs), which are predestined to recognize highly conserved molecular patterns including both pathogen-and damage-associated molecular patterns (PAMPS and DAMPs, respectively) (9, 10) . Recognition of these molecular patterns allows for rapid host defense while "mostly" maintaining nonreactivity to self (thorough recognizing only PAMPs and DAMPs) (9, 10) . This also paves the way for adaptive immune recognition that provides long-lasting immunity (11) . Indeed, cellular components of the innate system, namely antigenpresenting cells (APCs) such as macrophages and dendritic cells (DCs) (12) (13) (14) , as well as neutrophils (15) , bridge the interface between innate and adaptive responses. APCs, in particular, play pivotal roles in informing their adaptive counterpart (T and B lymphocytes) (16) for mounting antigen-specific responses with long-term memories that could also protect against future threats. The adaptive immune cells are highly antigen-specific (17, 18) and in a way to maintain self-tolerance, these cells cannot be activated solely by the initial recognition of antigen peptides through their somatically rearranged receptors (T cell receptor and B cell receptor, or TCRs and BCRs, respectively); instead, their activation also requires costimulatory and cytokine signals in addition to antigen recognition (19) (20) (21) . The co-stimulation signals ensure nonreactivity when encountering self-antigens, in which case peripheral tolerance (through deletion or anergy) would be induced (22) (23) (24) . However, it is complicated how deviations would occur and specifically, how the breach of selftolerance and autoimmunity would develop. According to the National Stem Cell Foundation, nearly 4% of the world's population are affected by one or more autoimmune disorders; and as of 2019, the National Institute of Health estimated that around 7% of adults in the United States had been diagnosed with autoimmune conditions. Based on organ specificity and possible etiology, autoimmune disorders can be tissue-specific, such as type 1 diabetes (T1D), multiple sclerosis (MS), and autoimmune thyroid disease (AITD); or affect multiple organs, such as systemic lupus erythematosus (SLE), Sjogren syndrome, and rheumatoid arthritis (RA) (25) . Different theories have postulated various mechanisms for autoimmune inflammation including the breakdown of central and/or peripheral tolerance (reviewed elsewhere) (26, 27) . Here, we summarize several possible mechanisms of immune dysregulation that could lead to systemic autoimmunity ( Figure 1 ). These mechanisms include (1) defective apoptotic cell clearance (28) , (2) defective apoptosis (29) , and (3) loss of suppressive regulatory controls leading to hyperactivation of autoreactive T and B cells. We choose SLE to illustrate how these interrelated mechanisms of immune dysregulation drive autoimmune pathogenesis leading to tissue damage. SLE is a systemic autoimmune disease with a mortality rate nearly 3 times of that in the general population (30) . There is no known cure so far. Autoimmune disorders arise as a result of the interplay among diverse factors including genetic, epigenetic, and environmental triggers (31) . The link between genetic susceptibilities (or inherited anomalies) and the skewness from homeostasis to autoimmunity has been extensively reviewed (32) (33) (34) (35) (36) (37) . Notably, genetic susceptibilities are far more complex than a single genetic mutation and commonly manifested as multiple genetic susceptibilities. Environmental factors can either potentiate or mitigate the effects of susceptibility genes, thereby having direct and indirect impacts on the development of immune tolerance and subsequent disease. The association between environmental exposure and the development of human autoimmune disorders (38) supports the widely accepted notion that environmental triggers can program immune responses. For instance, early-life exposure to infections, vaccines (39) , and dietary components (40) mold the immunological memory, consequently shaping how the immune system responds to exogenous stimuli later in life (41, 42) . During the recent decades, the tremendous increase in the prevalence of autoimmune conditions coincides with evolving dietary and hygiene styles in Westernized societies (43) , indicating a strong influence of environmental factors on autoimmunity (44) (45) (46) (47) (48) (49) . This is particularly important during pandemic eras since the emergence of unprecedented infections such as COVID-19 is thought to predominate among immunocompromised individuals such as those with preexisting autoimmune conditions who are also at an increased risk of COVID-19 related hospitalization (50). Indeed, autoantibodies against self-proteins such as type 1 interferons (IFNs) were found in cases of severe COVID infection and may account for COVID-19 deaths (51, 52) . Interestingly, a recent report has found an increased pre-existing prevalence of anti-IFNa autoantibodies in SLE patients with COVID-19 infection compared to SLE patients without COVID-19 (53) , suggesting that these autoantibodies might predispose SLE patients to contract COVID-19. Additionally, a recent study has shown that the activities of different exoproteome-directed autoantibodies (i.e., autoantibodies against immunomodulatory proteins such as cytokines, chemokines, complement components, and cell surface proteins) are dramatically increased in COVID-19 patients compared to uninfected controls (54) . In parallel, murine surrogates of these autoantibodies have been shown to exacerbate disease severity in a mouse model of SARS-CoV-2 infection (54), suggesting autoimmunity as a driving factor for severe COVID-19. Together, these studies indicate that pre-existing autoimmunity put autoimmune patients at a higher risk for more severe COVID-19 infection and subsequent mortalities. Conversely, it is believed that autoimmunity could be the comet tail following COVID-19 infection (54-56) especially in genetically predisposed individuals (57) . Therefore, it is crucial to understand the influence of environmental factors on autoimmune regulation to better protect the more vulnerable populations during the COVID-19 pandemic. Specifically, this pandemic has witnessed some unprecedented shifts in human dietary habits both positively (e.g., increased consumption of domestically cooked foods, increased shares of plant-based diets) and negatively (e.g., increased consumption of comfort food) (58) . At the same time, people are advised to practice stricter hygiene measures (59, 60) . Together these shifts in dietary and hygienic practices could on their own modulate our immune responses and/or autoimmune development or progression. In this review, we propose diet and hygiene as environmental regulators of immunity and discuss their influence on autoimmune development as depicted in Figure 1 . Dietary practices can influence immune tolerance and disease. Indeed, dietary components, including micronutrients and macronutrients, can affect both innate physical defenses such as epithelial barrier integrity (61) (62) (63) (64) , antimicrobial peptides (65) , and pro/anti-inflammatory cytokines (66) (67) (68) , as well as adaptive immune cell functionality (69) (70) (71) (72) . The high incidence of immune-mediated diseases such as autoimmune and allergic disorders in the Western world, where common themes of dietary behaviors exist including increased caloric (fat and carbohydrate) intake with much less fibers and imbalanced dietary fatty acid consumption, pinpoint the immunomodulatory capacities of these macronutrients and their potential causal implications on autoimmune development (47) . In contrast, dietary patterns that are mostly plant-based such as Mediterranean or DASH diets have been shown to contain anti-inflammatory and antioxidant components (73, 74) that could impose protective effects against autoimmunity (75). Among these, plant-derived phytochemicals including polyphenols (76) such as flavonoids (77) (78) (79) and isoflavones (80, 81) have been extensively investigated for healthful modulation of autoimmunity. To this end, the upside of the COVID-19 pandemic is its impact on the unprecedented dietary shifts to less processed and more plant-based dietary sources (82) . Interestingly, plant-based diets are associated with lower odds of moderate-to-severe COVID-19 and may provide protective support against severe COVID-19 infection (83) . Indeed, such dietary trends with COVID-19 emergence can not only benefit to restrain COVID-19 infection in normal people but also be supportive strategies for the vulnerable populations with autoimmune conditions. For example, quercetin is a natural flavonoid derived from different plant sources that has various antiinflammatory and antioxidant immunomodulatory capacities (84, 85) . Based on pharmacology and molecular docking, quercetin has been proposed as a potential protective treatment against acute renal injury, one of the most serious complications reported in hospitalized patients with COVID-19 infection (86) (87) (88) . At the same time, quercetin has been shown to attenuate various autoimmune pathologies in human and murine rheumatoid arthritis (RA) (89) (90) (91) (92) , and in experimental models of inflammatory bowel diseases (IBD) (93, 94) and SLE (95) . In the following section, we review how different micronutrients and macronutrients modulate immune health and autoimmune outcomes and discuss the potential advantageous roles of dietary manipulation in mitigating the risks of COVID-19 infection in autoimmune patients. Micronutrients including vitamins (such as vitamins E, A, and D) and minerals (such as selenium, copper, and zinc) are long known to possess capabilities to modulate immune responses. Micronutrients can tone every aspect of both innate and adaptive responses (96) . In the following section, we will discuss the role of vitamins and minerals in maintaining health and how their deficiencies contribute to autoimmune diseases. Vitamins have important functions in maintaining immune health through their antioxidant capacities (97) . There is a huge body of literature supporting the notion that oxidative stress plays a crucial role in autoimmune pathogenesis (98) (99) (100) . For instance, oxidative degradation of lipids that occur in the cellular membrane in a process known as lipid peroxidation is mediated by free radicals (101, 102) , which could impair the integrity of the cell membrane (103), induce cellular death (101) and accumulate apoptotic products, subsequently initiating autoimmunity (104) (105) (106) . In addition, intracellular oxidative signaling could increase the responsiveness of autoreactive immune cells such as T lymphocytes and drive their autoimmune pathogenicity (107) . Moreover, the extracellular release of oxidative products including reactive oxygen species (ROS) and proteases by innate immune cells such as neutrophils could initiate autoreactivity and lead to collateral tissue damage (108) . Interestingly, oxidative stress has also been proposed to be associated with COVID-19 pathogenesis (109) (110) (111) . Therefore, antioxidant vitamins could provide potentially beneficial supportive care for autoimmune patients with COVID-19. Here, we review the immunomodulatory functions of vitamins E, A, and D in autoimmunity and discuss their potential implications in COVID- 19 . Vitamin E (VE) as an antioxidant can diminish the secretion of ROS (e.g., by monocytes) (112) , thereby protecting against oxidative cell stress and indirectly maintaining immune cell functionality. Therefore, it has been suggested that the relative deficiency of VE could initiate autoimmunity (113) . Although data from human studies are not conclusive-where some reports showed that VE levels were increased in patients with systemic autoimmunity of primary Sjögren's syndrome (114) , while others correlated VE deficiency with the development of neurological complications of celiac disease (115) or showed no difference in VE levels in patients with IBD (116)-murine studies more decisively support the potential beneficial effect of VE in the treatment of autoimmune conditions such as RA (117, 118) . Importantly, based on data from murine lupus, VE is proposed as a safe treatment option for SLE (119, 120) where the supplementation reduces hallmarks of SLE such as the levels of anti-double-stranded DNA (anti-dsDNA) IgG antibodies (121) and counteracts oxidative stress (and lipid peroxidation) that would otherwise contribute to more debilitating SLE manifestations (122, 12 3) . In hu ma n studies, VE supplementation as part of a treatment regime improved the oxidative and nitrosative biomarkers and disease activity in SLE patients (124) . Vitamins A and D (VA and VD, respectively) are known to modulate the differentiation of immune cells, their tissue homing, and effector functions. On the innate arm, VD and VA have context/tissue-dependent functions that may antagonize each other. VD has been shown to mitigate the maturation of DCs, inhibiting their expression of maturation markers MHCII and CD80/86 (125) , as well as reducing their production of the proinflammatory cytokine IL-12 (126) , collectively inducing the tolerogenic phenotype of DCs (127, 128) . In contrast, VA has context-dependent effects on DCs. Although VA is a key player in the induction of mucosal tolerance (129) , it can also enhance DC maturation and their antigen-presenting capacities in the presence of pro-inflammatory stimuli (130) . In addition, VA can increase the expression of matrix metalloproteinase-9 (MMP9) to enhance the migration of inflammatory DCs to lymph nodes (131) . Together, these immunomodulatory capacities of VD and VA could represent a tango for in-vivo tuning of DC functions. Importantly, since DCs could modulate self-tolerance and the development of autoimmune disease such as SLE as we previously reviewed (132) , VD (133)-, and VA (134, 135)-mediated regulation of DC function could indirectly impact the development of tolerance and disease. On the adaptive arm, both VD and VA can affect the differentiation of T cell subsets, including T helper (Th)1 (proinflammatory) vs. Th2 (antiinflammatory), and T regulatory (Treg; immunosuppressive) vs. Th17 (proinflammatory) as depicted in Figure 2 . For example, VD (67, 125, (136) (137) (138) and VA (139) (140) (141) have been shown to inhibit Th1 differentiation and responses while supporting the development and responses of Th2 lymphocytes. In addition, both VD (142, 143) and VA (144) (145) (146) potentiate the development of Treg over Th17. Importantly, the imbalance between these different T cell subsets is a driving force for autoimmune development (147, 148) . Ecological associations between low VD levels and the incidence of different autoimmune conditions such as IBD, MS, T1D, and RA have been reported in areas with limited sun exposure (149) (150) (151) . It is widely hypothesized that deficiency of VD is associated with the development of different autoimmune conditions where polymorphism in VD receptors (VDR) are implicated among the causal risks for autoimmune conditions including AITD (152, 153) , T1D (154), MS (155), RA (156) and SLE (157) . In addition, VD deficiency is associated with more aggravated autoimmune flares in SLE (158-161) by promoting memory B cells responses (162) and subsequent autoantibody production (163) . These observations strengthen the potential use of VD supplementation to control autoimmune disease (164) . Importantly, plasma (165) and serum (166) levels of VD have been shown to be depleted in COVID-19 patients. Additionally, low levels of VD are also correlated with the severity of COVID-19 progression in those patients (166) . Meanwhile, VD supplementation during or just before COVID-19 contraction can mitigate disease progression and enhance the survival rate in infected patients (167) . Together these reports support the potential healthful effect of VD in autoimmune patients to combat COVID-19 severity and fatality. In contrast, it remains to be determined if VA deficiency or polymorphisms in VA receptors are causally associated with autoimmune development. Although serum retinol levels have been negatively correlated with MS activity (168) , and hypovitaminosis A has been detected proceeding the clinical diagnosis of SLE (169, 170) , it is still to be elucidated whether VA deficiency is a driving factor for autoimmunity. Due to their immunomodulatory capacities, retinoids have been proposed as potentially beneficial adjuvants controlling autoimmune disorders (171) . The most active metabolite of VA, all-trans-retinoic acid (tRA), has been shown to control pathogenic T cell subsets such as IL-17 secreting gd T cells and sufficiently ameliorate experimental autoimmune encephalitis (EAE), a murine model of MS. Similarly, we and others have shown the protective effects of VA on murine SLE especially during the active stage of the disease (172) (173) (174) . In future investigations, we propose to (1) investigate the potentially detrimental effects of VA deficiency on the progression of renal inflammation in genetically-prone SLE, and (2) delineate the molecular and transcriptional mechanisms by which hypovitaminosis A promotes systemic autoimmunity. Importantly, a recent study conducted in hospitalized COVID-19 patients with respiratory failure showed that serum retinol levels were significantly lower compared to healthy controls (175) . This report's findings support the idea that COVID-19 infection is associated with retinoic acid depletion syndrome (176) and that VA supplementation might be a beneficial approach especially in areas of limited medical resources (177) . Therefore, considering its complex roles in modulating autoimmunity, VA might be a crucial element to be considered for monitoring and supplementation as needed for autoimmune patients with COVID-19 infection. It is important to note that for clinical applications, optimal levels of these vitamins as combinations may be crucial for achieving the harmony of their action. Future investigations on the vitamins' modulation of autoimmunity as an overlapping circuit rather than solo-induced effects will shed more light on their therapeutic potential in clinical settings. Minerals, or specifically trace elements such as selenium, copper, and zinc, modulate immune functions in various indirect ways. Generally, minerals can have antioxidant capacities and consequently maintain the structural integrity of essential biological molecules (e.g., maintaining cell membrane stability) (178) , participate in enzymatic activities (179) , and potentiate energy production and use during cellular metabolism (180) . Importantly, some trace elements are needed to facilitate cell signaling (181, 182) , where their binding to target ligands/ receptors regulates essential processes including gene expression and protein synthesis (183, 184) . Selenium, for example, acts as an antioxidant, eliminating free radicals and subsequently maintaining immune system functions (185) . It also has catalytic activities and is essential for the enzymatic activity of glutathione peroxidase to inhibit lipid peroxidation (186) . This is particularly important for protecting cell membrane phospholipids, consequently maintaining cell membrane structure and preventing oxidative mitochondrial damage in immune cells such as macrophages (187) (188) (189) . Therefore, selenium deficiency is associated with increased inflammation (190, 191) and autoimmunity as in celiac disease and AITD (192) . Similarly, meta-analysis of genome-wide association studies (GWAS) have predicted high selenium levels to be associated with a decreased risk for SLE (193) . Indeed, selenium supplementation in murine models of SLE has been shown to improve survival (194) and mitigate various hallmarks of the disease including splenomegaly and autoantibody production (195) . In addition, a recent cohort study has shown that severe COVID-19 patients exhibit a pronounced deficit in total serum selenium and selenoprotein levels, and that selenium status is significantly higher in COVID survivors compared to non-survivors, suggesting the therapeutic potential of selenium supplementation in severely diseased and/ or selenium-deficient COVID-19 patients (196) . Aside from these non-specific immunomodulatory capacities, minerals can directly modulate both innate and adaptive immune cell activities and be involved in the activation of key signaling molecules such as NF-kB. Zinc, for example, can be both pro-and anti-inflammatory and plays an essential role in maintaining both innate and adaptive cellular responses (197) . Zinc promotes NF-kB signaling and subsequently the production of pro-inflammatory cytokines from macrophages (198, 199) . The utilization of zinc by macrophages enhances their phagocytic activities (200, 201) . Therefore, lower circulatory levels of zinc could be linked to macrophage-related autoimmune diseases such as RA (202) . Meanwhile, zinc can also induce tolerogenic DCs in both in-vivo and in-vitro settings (203) . Thus, zinc deficiency could compromise the interface between innate and adaptive immunity leading to skewing of Th cell balance (203) . Zinc is essential for T lymphocyte proliferation (204) and activation (205) through promoting IL-2 signaling. It also promotes the upregulation of IL-12 signaling and Th1 transcription regulator T-bet (206) . Consistently, zinc deficiency reduces the levels of Th1polarizing cytokines (e.g., IFNg) (207) . Therefore, a shift of Th1/Th2 balance to Th2 has been linked to zinc deficiency. However, zinc can enhance the differentiation of Treg cells through upregulating FOXP3, where it increases the phosphorylation of Smad proteins, allowing for its binding to the Foxp3 promoter (208) . Furthermore, zinc can suppress Th17 differentiation through inhibiting signal transducer and activator of transcription 3 (STAT3) signaling (209) as well as memory Th17 responses via inhibition of the IL-1b/IL-1 receptorassociated kinase 4 (IRAK4) phosphorylation (210) . Thus, zinc can benefit by tuning T cell-driven autoimmunity as shown in EAE (211, 212) . In human studies, lower systemic zinc levels have been reported in different autoimmune conditions (213) including MS (214) and SLE (215, 216) . Interestingly, COVID-19 patients also have lower zinc levels that are correlated with disease complications and prolonged hospital stays (217) . Together, these studies warrant further investigation on the immunomodulatory capacities of zinc in autoimmune and/or other high-risk patients for COVID-19. In summary, micronutrients are essential for fine-tuning the development and function of immune cells. Altered homeostasis of micronutrients as seen in various autoimmune diseases could critically influence immunity and promote autoimmune dysregulations. It is noteworthy that although evidence-based findings are still being uncovered on the causal relationship between micronutrient deficiencies and more severe COVID-19, as well as the potential healthful effects of micronutrients on COVID convalescence, the immunomodulatory functions of micronutrients may support their roles in combating COVID-19 infection (218-220). Therefore, for autoimmune patients in the COVID-19 pandemic, the potential benefits of micronutrients as discussed above urge for regular monitoring of their levels and if deemed necessary, supplementations in individuals with specific micronutrient deficiencies. Macronutrients have diverse immunomodulatory functions that dynamically modulate immune cell responses to shape autoimmune outcomes. Data exploring the implication of specific macronutrients in COVID-19 are lacking. However, it is well established that overconsumption of energy-yielding macronutrients could lead to obesity (221), a condition considered as one of the major risk factors of severe COVID-19 infection (222) (223) (224) (225) . Here, we review current knowledge on the modulation of autoimmunity by different macronutrients and discuss points to be considered with regards to COVID-19 infection in autoimmune patients. (e.g., lactose), and monosaccharides (e.g., glucose and fructose) (226) . Carbohydrates, especially non-digestible polysaccharides and oligosaccharides (e.g., in prebiotics), exert both direct and indirect immunomodulatory capacities. Indirectly, they act as a source of energy for gut microbiota which, in turn, could modulate immune responses via different mechanisms as previously reviewed (227, 228) . Directly, they could modulate both innate and adaptive effector immune functions involving epithelial tight junctions, cytokine/chemokines, and antibody production as reviewed elsewhere (229) . Indeed, dietary polysaccharides are sensed by different immune cell receptors including complement receptor 3 (CR3), Toll-like receptor (TLR) as well as dectins (carbohydrate-binding proteins) (230) ; subsequently, they act as immunogens to stimulate immune responses. Notably, plant polysaccharides can be the interface linking innate and adaptive immune cell activation. They primarily stimulate the proliferation and activation of innate cellular components such as natural killer (NK) cells (enhancing their cytotoxic activities) and macrophages (augmenting their production of TNFa and IL-6 as well as their lysosomal activities and nitric oxide production) (231) . In turn, these innate components activate their adaptive counterparts, inducing Th cell differentiation and antibody production from B cells as previously detailed (231) . The effector functions of immune cells rely primarily on glucose (232) . Therefore, it is not surprising that high carbohydrate intake could exacerbate the hyperactivation of immune cells in chronic inflammatory and autoimmune conditions. Indeed, modern diets containing high levels of processed fructose-rich carbohydrates increase the incidence of chronic inflammation (233, 234) . High glucose intake augments ROS-dependent activation of TGFb and consequently the induction of Th17, thereby exacerbating autoimmune conditions as reported in murine models of MS (i.e., EAE) and colitis (235) . In addition, excessive carbohydrate intake increases the levels of circulatory inflammatory markers such as IL-6 and C-reactive proteins (CRP) in SLE patients (236) . In contrast, natural glucose derived from plant-based carbohydrates such as cell wall-based cellulose (which is an insoluble fiber and composed of unbranched b-1,4-linked glucose monomers) has been shown to reduce the frequency and number of proinflammatory T cells and promote autoimmune suppressive Th2 responses in EAE (237) . These findings illustrate the pivotal effects of dietary carbohydrates on immune cell functions and warrant further investigations towards more mechanistic insights with a specifi c emphasis on autoimmune modulation. It is also crucial to maintain a balance between carbohydrates and other macronutrients including dietary fats and proteins. Although plant-based lipids (e.g., phytosterol from vegetable oils) could beneficially modulate autoimmune inflammation as reported in EAE (238, 239) , it is controversial how fat-modulated diets precisely shift immune responses and subsequently autoimmune progression. If only the level of fat consumption is changed, reduced dietary fat levels increase the proliferation of human peripheral blood mononuclear cells (PBMCs) following both mitogens and inflammatory cytokine stimuli (240) , suggesting better responses to pathogenic invaders (241) . However, recent studies propose that ketogenic diets of low carbohydrate and high fat intake potentiate more protective gd T cell responses against infectious triggers (242) . This emphasizes the importance of considering the levels of all macronutrients together when assessing immune modulation under steadystate conditions. Under autoimmune conditions, on the other hand, a large pool of evidence proposes that a high-fat diet (HFD) adversely impacts the immunopathogenesis of different autoimmune diseases as widely investigated in SLE (243) . For example, high fat intake resulted in defective phagocytic and cytotoxic activities of macrophages and NK cells, respectively, and this was associated with earlier onset and exacerbated autoimmunity in lupus-prone NZB/W F1 mice (244) . In addition, HFD further increased TLR7 expression and signaling in TLR8 knockout mice (a spontaneous murine lupus model characterized by increased TLR7 signaling) leading to exacerbated kidney inflammation due to increased production and renal deposition of autoantibodies (245) . Furthermore, HFD-induced obesity increased the T follicular helper (Tfh) cell activity in MRL/lpr mice and consequently the activation of B cells, exacerbating SLE-associated splenomegaly and potentiating IgG production and their glomerular deposition (246) . In contrast, a low-fat, isoenergetic diet designed to provide no more than 20% energy from fat a day, together with supplementation of 1 g of fish oil, effectively attenuated disease activity in SLE patients (247) . Although it is yet to be tested whether high fat/low carbohydrate ketogenic diets are beneficial in SLE patients, a potential positive effect of ketogenic diets has been reported for some autoimmune patients with MS (248) or T1D (249) . Interestingly, a ketogenic diet may also provide supportive care for COVID-19 patients (250), reducing their need for the intensive care unit (251) . This again emphasizes the importance of considering the levels of all macronutrients together on immune modulation under autoimmune status and highlights the importance of personalized care plans for autoimmune individuals with COVID-19 infection. Not only the quantity but also the type of consumed fat could differentially affect the immunopathogenesis of autoimmunity. Dietary fats could be in the form of saturated fat, trans-fat and unsaturated fat. Increased intake of saturated fat accelerates the disease relapse in children with MS (252) . Increased consumption of trans-fat increases the levels of free radicals that damage the integrity of immune cell membranes and contribute to autoimmunity (243) . In contrast, the incorporation of Mediterranean diets that significantly increases the ratio of unsaturated to saturated fats has been linked to improved autoimmune pathologies (e.g., alleviating RA symptoms) (253) . Notably, a diet rich in polyunsaturated fatty acids (PUFA) can improve the overall clinical scores and elicit anti-inflammatory effects in SLE (254) . Similarly, a recent report has shown a negative correlation between adherence to Mediterranean diets and COVID-19 cases in Spain and other countries (255) , supporting a potential protective role of PUFArich Mediterranean diets against COVID-19 (256, 257) . Indeed, supplementation of PUFA such as omega-3 (w−3) augment the activities of antioxidant enzymes and diminish autoimmunity (243) . Several studies have shown that w−3 enriched diets dramatically reduce SLE-associated inflammatory markers, lupus progression (mitigating glomerulonephritis) and improve survival in different mouse models of SLE (258) (259) (260) (261) (262) . This is achieved mostly through potentiating the effects of antioxidant enzymes (such as superoxide dismutase and glutathione peroxidase) which, in turn, potentiate the ability of renal cells to eliminate harmful free radicals (e.g., reactive oxygen intermediates) (259, 261) . Moreover, a diet rich in w−3 (e.g., with fish oil) reduces the level of anti-dsDNA antibodies (258, 261) , circulating immune complexes, and their renal deposition (258) . Furthermore, fish oil can reduce the expression of renal pro-inflammatory cytokines including IFNg, IL-12, TNFa (259, 261) , and renal profibrotic molecules such as TGFb and fibronectin-1 (261). By downregulating these molecules, fish oil diminishes the ageassociated activation of NF-kB signaling in lupus mice, thereby mitigating lupus nephritis (259) . Indeed, fish oil is a dietary source for w−3 PUFA that exerts anti-inflammatory capacities through dampening immune cell responsiveness to IFNg (263) . Recent findings have shown that w−3 PUFA could also downregulate biomarkers associated with T and B cell activation and/or differentiation and leukocyte recruitment such as CD80, CTLA-4, IL-18, CCL5, CXCR3, IL-6, TNFa (264) . Similarly, they mitigate inflammatory markers associated with intestinal inflammation/colitis such as IL-6, inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and leukotriene B 4 (LTB 4 ) (265). Collectively, these beneficial actions of w-3 PUFA on autoimmune development (especially SLE) could be targeted in future human intervention studies. Interestingly, for their immunomodulatory capacities, w−3 PUFA have been recently proposed as part of the supportive care for COVID-19 patients (266, 267) , as recent pilot data suggest that a higher w-3 index may lower the risk of COVID-19 fatality (268) . Therefore, diets rich in PUFA might confer benefits for autoimmune patients with SARS-CoV-2 infection. Dietary proteins are the third component of macronutrients in a balanced diet and are hydrolyzed in the gut to generate amino acids and peptides. Proteins can, directly and indirectly, modulate immune functions. Directly, dietary proteins-derived amino acids can serve as major energy sources for leukocytes, enhance the development of immune cells from hematopoietic progenitors, and modulate their effector functions as previously reviewed (269) . Indirectly, proteins are utilized through gut microbiota which in turn mediates the interplay between protein metabolites and the host immune system as detailed elsewhere (270) . Indeed, exposure to dietary protein antigens is necessary for the maturation of the immune system (271, 272) . Feeding of weanling mice a protein-deficient diet that had only free amino acids resulted in a poorly developed immunological profile that resembled that of newborn or germ-free (GF) mice (271, 273) , which is characterized by reduced secretory IgA and systemic Ig levels as well as less-developed gut-associated lymphoid tissues (271, 273) . Moreover, in addition to playing an integral role in the development of oral tolerance (273, 274) , early-life intake of protein antigens is crucial for Th1 differentiation (271) , B cell responses, and class switching (275) , thereby helping to augment the immunity against infectious invaders later in life (272) . Together, these studies suggest that dietary protein malnutrition (PM) could adversely impact immunity. Interestingly, both PM and excessively high protein intake could exacerbate inflammation. PM could potentiate intestinal mucosal damage following inflammatory stimulation (e.g., zymosan-induced systemic inflammation), allowing bacterial translocation and gut-induced septicemia (276) . In parallel, in contrast to proteins from plant origins that could mitigate inflammation (277), a high-protein diet, especially from animal origin, aggravates both acute and chronic dextran sulfate sodium (DSS)-induced colitis via promoting the pro-inflammatory responses of macrophages (278) . Furthermore, high protein intake has been associated with deterioration of renal disease involving glomerular hyperfiltration (279) . Meanwhile, a low-protein diet could help the management of chronic kidney diseases (280) . As kidney inflammation, namely lupus nephritis is the most lifethreatening manifestation of SLE, modulation of protein intake could be of great importance. Indeed, moderate dietary protein intake of 0.6 g/kg daily improves renal functions in SLE patients (281) . Restriction of protein intake in NZB/W F1 mice improved the disease outcome, inhibited splenomegaly, and maintained immune cell responsiveness to mitogenic stimulation (282) . Together, these observations suggest that dietary protein modulation can influence immune components in the pathogenesis of autoimmune disorders such as SLE, therefore warranting further studies to elucidate the underlying cellular and molecular mechanisms. Epidemiological association between obesity and autoinflammatory disorders (283) suggests that excessive caloric/energy intake could lead to the breakdown of immunological tolerance. Excess caloric intake in early life increases the incidence of IBD (284) and autoimmune thyroiditis (285) in adulthood. In contrast, caloric/ energy intake restriction (EIR) can improve the autoimmune/ inflammatory outcomes as have been reported in experimental models of SLE (286) (287) (288) (289) (290) (291) , EAE (292) (293) (294) (295) , and Sjogren's syndrome (296) . Immune responses are high energy-dependent to fuel the biosynthetic needs of activated immune cells. The bioenergetic demand of immune cells is achieved via three interconnected metabolic pathways including oxidative phosphorylation (which occurs in the mitochondria of naïve cells), glycolysis (which occurs in the cytoplasm of activated and proliferating cells), and tricarboxylic acid (TCA) cycle (which occurs in the mitochondria of activated and proliferating cells) (232). The immune system is dynamically active with continuous changes in cellular activities such as those between resting naïve cells and proliferating effector cells, and those of memory/long-lived cell populations that might be quiescent but ready to undergo rapid proliferation upon stimulation. Therefore, the cellular energy demand is variable based on the phases and activities of immune cells (297) (298) (299) . For instance, for a cell in a resting state (e.g., naïve T or B cells), the need for energy will be towards maintaining its minimal metabolic and biosynthetic requirements that are directed for building cellular components. Therefore, the cellular energy expenditure is met through oxidative phosphorylation and targets preserving cellular integrity. In contrast, effector immune cells undergo rapid proliferation and have a wide range of effector functions as represented in the production of effector molecules such as cytokines, chemokines, inflammatory mediators, and immunoglobulins. This will require upregulation of fuel uptake and aerobic glycolysis to satisfy higher metabolic configurations needed for both bioenergetic and biosynthetic pathways (297) (298) (299) . Importantly, these shifts of cellular energy phases could be largely dependent on nutrient and energy supplies in the microenvironment. Moreover, energy/caloric intake can influence cellular metabolism as well as phenotypic and functional capacities of immune cells (300) (301) (302) . For instance, due to chronic metabolic stress leading to ATP depletion, chronically activated T cells in SLE patients fulfill their need for ATP through oxidative phosphorylation rather than upregulating the aerobic glycolysis (303) . In parallel, continuous low-grade inflammation due to excess energy intake (as in obesity) exacerbates the proinflammatory phenotype of different immune cells, favoring the differentiation of Th1 and Th17 subsets while diminishing the frequency of Treg cells (304) , thereby predisposing individuals to autoimmunity (283) . (305) (306) (307) , which subsequently turns on the mammalian target of rapamycin (mTOR) pathway, where mTOR is of two functional complexes, mTORC1 and mTORC2 (308) . mTOR is a central regulator for T cell differentiation and homeostasis (309, 310) . Under normal nutrient and energy conditions, mTOR (especially mTORC1) senses the microenvironment and upregulates the expression of glycolytic genes (311), allowing for biosynthetic anabolic processes needed for cell proliferation (309) . However, excessive functions of mTOR can disrupt cellular differentiation and predispose individuals to autoimmune conditions such as RA (312) and SLE (313) . Augmented mTOR activities under autoimmune conditions are not limited to T cells, where mTORC1 expands pathogenic T cell populations including Th17 and the CD4 -CD8doublenegative T (DN-T cells) while suppressing Treg cells (313) ; but also B cells (314) (315) (316) , DCs and macrophages (317, 318) . Activation of mTORC1 precedes the onset of SLE as a result of chronic metabolic stress with long-term ATP depletion and mitochondrial hyperpolarization (319, 320) . In contrast, during energy restriction, rapid inhibition of mTOR occurs, allowing the shift to catabolic processes to maintain the energy required for cell survival (321, 322) ; at the same time, Treg cells become responsive to TCR stimulation, thus enhancing their proliferation (323) . Therefore, optimizing the cellular metabolic shifts could open new therapeutic avenues for the treatment of autoimmunity (324, 325) . Consistent with this notion, EIR can suppress the immunopathogenic responses associated with autoimmunity and chronic inflammation including hyperactivation of cellular and humoral responses (326) . For instance, EIR reduces antigen processing by macrophages as well as the T cell-dependent activation of B cells (326) . Similarly, EIR diminishes the inflammatory activities of circulating monocytes and their mobilization from the bone marrow without compromising their emergency egression during acute infection and tissue repair (327) . Through these mechanisms, EIR has been shown to modify the autoimmune/inflammatory pathogenesis of various disorders (286) (287) (288) (289) (290) (291) (292) (293) (294) (295) (296) . For example, EIR can dampen the SLE progression. Early dietary modulation through caloric restriction by the time of weaning reduces SLE-associated lymphadenopathy in mice (328) . Caloric restriction significantly reduces B cell frequencies and their activation (291) , reduces circulatory anti-dsDNA antibodies, and prevents the increase of possibly pathogenic T cell subsets such as DN-T cells (329) , while maintaining a higher percentage of naïve T cell subsets (291) as well as the responsiveness of lymphocytes to mitogenic stimulation (329) . In addition, lupus-prone NZB mice with chronic energy/calorie intake restriction (CEIR; fed a 40% caloric reduction diet that was relatively low in fat and high in carbohydrates) prolongs the survival and delays the disease initiation (286) . In NZB mice as well as other lupus-prone murine models including MRL/lpr and BXSB, CEIR diminishes proliferation of lymphoid cells in the spleen, thymus, and mesenteric lymph node (MLN) (287) , downregulates the transcript levels of proinflammatory cytokines such as IFNg and IL-12, reduces IgA and IgG2a autoantibodies (288) , and decreases molecules associated with fibrinogenesis such as platelet-derived growth factor (PDGF) (289), subsequently ameliorates lupus-associated kidney inflammation or glomerulonephritis. These observations emphasize the potential use of EIR in the treatment of SLE. In summary, calorie restriction (e.g., intermittent fasting) and fat/carbohydrate modulation (e.g., ketogenic diets) may provide novel opportunities against autoimmunity by regulating both adaptive and innate immune activation pathways (242, 330) . However, further studies are warranted to establish the safety and clinical efficacy of immunometabolic treatment strategies in autoimmunity. In parallel, it is essential to ensure that the modulated diets do not lead to malnutrition that promotes immune dysfunction and increases the risk and severity of infections (331) . Notably, malnutrition predisposes COVID-19 patients to more severe disease in an age-dependent manner (332) and increases the odds of their fatality (333) . Indeed, COVID-19 patients may require higher energy intake and increased protein consumption (334) , and it is a necessity to consider the immunomodulatory influence of macronutrients for proper supportive managements of autoimmune patients with COVID-19 infection. In Table 1 , we present a short list of several nutrients that have shown beneficial effects in murine models of SLE where human studies are warranted. According to the hygiene hypothesis, microbial stimulation might be particularly crucial for immune education during early life, leading to less self-reactivity, thereby mitigating the development of autoimmunity later in life. This might be conceivable since both neonatal innate and adaptive defenses are biased towards maintaining tolerance developed in utero (as reviewed elsewhere) (341, 342) . For instance, neonatal APCs have reduced antigen-presenting and costimulatory capacities (343, 344) . Similarly, neonatal T cells have a default programming toward a Treg phenotype (345) and exhibit more bias toward Th2 cell responses (346) . Together, these evidences could explain the increased susceptibility to infections and higher disease morbidity in neonates (347) . Interestingly, challenging the neonatal defenses with infections reshapes their immune responses (348) and could modulate responses during inflammatory and autoimmune processes later in life (349) . Indeed, besides the interaction with dietary antigens (as we discussed above), early-life maturation of the immune system and the development of immunological tolerance are achieved through immense pressure from microbial stimulation in our surroundings (349, 350) , where microbial influences create a balance between protection and tolerance (351) . For instance, commensal microbial colonization limits the expansion of pathogenic/disease-causing pathobionts (352, 353) , and more importantly, colonization of commensal microbes early in life can induce Treg cells on mucosal sites (such as the lungs) and subsequently promote homeostasis and tolerance later in life (354, 355) . In contrast, microbial depletion or reduced microbiota diversity [e.g., through antibiotic treatment early in life (356) ] can have long-term immunological consequences (357, 358) , where the lack of microbial diversity during the neonatal stage could lead to a higher incidence of chronic inflammatory and topical disorders later in life (359) . Cases of hyperinflammatory responses that could fit within the criteria for autoimmune disorders have been reported following COVID-19 infections (360) (361) (362) (363) (364) (365) (366) . This leads us to the question of whether the viral infection itself could contribute to the breakdown of self-tolerance. It is widely accepted that infections could trigger autoimmunity (367) (368) (369) (370) (371) (372) . Mechanisms of such include (1) bystander activation of innate cells enhancing the presentation of self-antigens and thereby the expansion of autoreactive adaptive counterparts, (2) release of autoantigens, neoantigen formation, and epitope spreading following excessive tissue damage, thus promoting autoimmunity, and (3) induction of molecular mimicry or cross-reactivity when both infectious/ exogenous antigens and self-antigens share sequence or structural similarities leading to autoreactivity against self (367, 373) . In this regard, although data are still needed on the ability of SARS-CoV-2 to induce bystander activation and neoantigen formation, the non-specific activation of innate immune cells generating a wide array of pro-inflammatory cytokines (e.g., cytokine storms) following COVID-19 infection (374) may lead to tissue damage and generation of neoantigens or epitope spreading, thus initiating autoimmunity. Consistent with this notion, it was previously reported that in severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infection, the presence of cross-reactive epitopes on SARS-CoV spike protein domain 2 could generate antibodies that also cross-reacted with epitopes on lung epithelial cells (375) . Similarly, recent reports have shown that based on transcriptomic analysis, SARS-CoV-2 shares molecular similarities with diverse human central nervous system (CNS) protein epitopes that could trigger CNS autoimmunity (376) . On the other hand, infections could be a double-edged sword where different hypotheses exist on how infections could modulate autoimmunity. As postulated by the hygiene hypothesis, infections could counteract autoimmune development and represent a therapeutic intervention against autoimmunity. Notably, there are compelling evidences that specific pathogens suppress different autoimmune conditions in murine models of SLE (377) , CNS autoimmunity (378) and T1D (379) . Generally, the potential mechanisms that might explain the protective influence of infections on autoimmunity [as reviewed by others (44) ] include (1) antigenic competition where a strong immune response is induced by a stronger antigenic stimulus from an infectious agent competes on signals of inflammation (e.g., pro-inflammatory cytokines) with a weaker signal from autoantigens leading to dampened responses towards the weaker stimulus (380), (2) desensitization of antigen recognition receptors such as TLRs due to repeated low-dose antigenic stimulation leading to anergic responses to autoantigens (381) (382) (383) (384) , and (3) induction of immunosuppressive phenotype or bystander suppression where infectious agents enhance the signaling that rebalances the regulatory to pro-inflammatory T-cell subsets by increasing the Treg cells and limiting Th17 expansion (385) . Furthermore, based on the hygiene hypothesis, or the microbiome d epletion the ory, there is a p ositive epidemiological association between the increase of countermeasures to limit infections (e.g., antibiotics, vaccinations, and sanitation strategies) and the incidence of autoimmune and allergic conditions (45) . During the COVID-19 pandemic, the worldwide increase of sanitation strategies and the use of numerous types of disinfectants and household products raise concerns around their implications on immune health, especially with the concomitant emergence of allergic and autoimmune conditions (386) . Could hygiene measures and specifically the use of disinfectants affect the microbial and immunological modulation of autoimmunity? Although studies investigating the immunopathogenic potential of disinfectants are limited, here we briefly propose three possible mechanisms of how disinfectants could modulate immunity and contribute to autoimmune conditions such as SLE. These include their effects on (1) microbiota diversity, (2) immune cell phenotype and fate, and (3) epigenetic modifications. Hygiene can disrupt microbiota diversity (387) (388) (389) , and a positive correlation has been found between microbiota dysbiosis and the increase of autoimmune conditions such as IBD (390) (391) (392) and SLE (393) (394) (395) (396) (397) . This concern is escalating due to the (170) . • Investigating whether VD deficiency is a cause or a sequelae to autoimmune progression. • Reforming genetic association data linking certain genetic susceptibilities and possibilities of VD deficiency for better personalized therapeutic approaches. • Establishing the desired doses for prophylactic and/or therapeutic supplementation of VD for SLE patients. • Testing the potential efficacy and safety of VD supplementation on SLE-associated inflammatory and hemostatic markers in long-term studies. • Supplementation of all-trans-retinoic acid (tRA) to murine lupus models drove disease-stage dependent effects on the development of lupus nephritis. During the active disease stages in MRL/lpr and pristane-induced lupus mouse models, tRA oral dosing showed beneficial effects on renal inflammation (172) (173) (174) . • Hypovitaminosis A has been detected preceding the clinical diagnosis of SLE (169) . • Investigating whether VA deficiency is a driving factor for SLE progression. • Genome-wide association studies to establish whether polymorphisms in VA receptors are causally associated with SLE development. • Determining the desired doses of prophylactic and/or therapeutic supplementation of VA. • Testing the safety and efficacy of VA supplementation in SLE patients with different disease manifestations. Se • Se supplementation improved the survival in NZB/NZW F1 mice (194) . • SE treatment attenuated SLE-associated splenomegaly in B6.Sle1b mice (195) . • SE supplementation in B6.Sle1b mice significantly reduced total and germinal center B cell numbers, and anti-dsDNA and anti-SmRNP autoantibodies (195) . • Meta-analysis of genome-wide association studies predicted high Se levels to associate with a decreased risk for SLE (193 (259, 261) , and renal profibrotic molecules such as TGFb and fibronectin-1 (261). • Fish oil (the marine source of w−3) together with a low-fat diet significantly modified SLE activity (247) . A population-based study suggested that a higher dietary intake of w−3 fatty acids and lower w−6: w−3 ratios were positively associated with patient-reported favorable outcomes of SLE activity index (340) . • Conducting longer-term trials with larger patient sample sizes to establish the long-term outcomes of w−3 PUFA supplementation on the SLE activity index. • Determining the therapeutic efficacy and safety of w−3 PUFA as part of the therapeutic regimes that include other immunosuppressive agents. current COVID-19 pandemic that witnessed a dramatic increase in hygiene practices including the use of detergents and disinfectants (398) (399) (400) . In fact, these control measures may have long-term consequences on the human microbiome (401, 402) . Importantly, a recent report suggests that a disturbed gut microbiota might lead to more severe inflammation in COVID-19, where they found positive correlations between microbial dysbiosis and disease severity as well as inflammatory mediators in COVID-19 patients (403) . The use of disinfectants is well established to alter microbiota diversity and microbial load. Chlorine, which is widely used as a water disinfectant, produces byproducts called trihalomethanes (THMs) that are intestinally absorbed and known to perturb the gut microbiota leading to the elevated relative abundance of Bacteroidetes and a dose-dependent decrease in the ratio of Firmicutes to Bacteroidetes (404) . Similarly, a reduced Firmicutes/Bacteroidetes ratio is also evident in different autoimmune diseases (405, 406) including SLE (407) . The active chemicals in commercial disinfectants and hand sanitizers (e.g., Triclosan, 5-chloro-2-(2,4-dichloro phenoxy) phenyl) could have a profound impact on the gut microbiome (408, 409) , reducing microbiota diversity (410, 411) and increasing the abundance of Lachnospiraceae (412) . As mentioned earlier, there is a strong correlation between disrupted microbial communities and systemic autoimmune disease pathogenesis. For instance, in MRL/lpr mice, reduced Lactobacillaceae and increased Lachnospiraceae are associated with lupus onset and progression (413) . Thus, COVID-19 related hygiene practices, such as the overuse of disinfectants, could indirectly contribute to autoimmunity through inducing microbiota dysbiosis. Secondly, the use of disinfectants could also tone the function and fate of immune cells and subsequently shape the outcome of autoimmune disease. We have shown that quaternary ammonium compounds (QACs) in widely used antiseptics and surface disinfectants (414) can impair innate immune cell functions (415) . QACs increase the production of proinflammatory cytokines from murine macrophages in vitro and paradoxically impair their phagocytic potential (415) . Since prompt macrophage responses are crucial for efferocytosis (phagocytosis of dying cells in an inflammatory milieu) as well as effective clearance of autoantigens, these disinfectants could contribute to autoimmunity via impairing macrophages responses (416, 417) . Using MRL/lpr mice, we found that ambient exposure to QACs hindered the migration of bone marrow-derived neutrophils towards inflammatory stimuli and decreased their infiltration into the lymph nodes. In parallel, QACs upregulated splenic neutrophil expression of checkpoint protein programmed death-ligand 1 (PD-L1). Moreover, QAC exposure dampened the activation of splenic T cells and increased apoptosis of effector T-cell populations, thereby mitigating SLE-associated lymphadenopathy in this mouse model (418) . Furthermore, while the phenotype of reduced splenomegaly and lymphadenopathy is an indication of protection against a mouse model of SLE, our findings also indicate that even ambient exposure to QACs could alter neutrophil and T-cell phenotypes, functions, and their fate, raising concerns about the immunotoxicity of these chemicals. Thirdly, disinfectants may reprogram immune cell functions through epigenetic alteration, thus leading to autoimmunity. For instance, long-term exposure to the chlorine byproducts THMs in drinking water results in global DNA hypomethylation as well as c-Jun gene-specific hypomethylation (419) . Inhibition of DNA methylation in differentiating Th cells deviates their cytokine responses towards a pro-inflammatory IFNg + phenotype (420) . In addition, a low DNA methylation level in mature T cells could result in T-cell autoreactivity associated with idiopathic SLE (421) . These findings on disinfectants and epigenetics warrant further investigations to elaborate their roles in breaking immune homeostasis to promote autoimmunity. Importantly, while authorities worldwide are more interested in mitigating the spread of COVID-19 infection, the long-term consequences of hygiene strategies on immune modulation need to be addressed. The Centers for Disease Control and Prevention (CDC) recommends to the use of the United States Environmental Protection Agency (EPA) list N-approved disinfectants to combat COVID-19 infection; if the disinfectants on the list are not available, then the bleach solution (Chlorine) is recommended. Notably, QAC-based disinfectants are on the top of the EPA list N. Again, the CDC recommendations raise the concern of whether the overuse of these chemicals by the public could pave the way to autoimmunity as the comet tail of the current pandemic. As we have discussed, QACs and chlorine byproducts have the potential to modulate immune cell fate and induce epigenetic modification, respectively, to break self-tolerance, thus leading to autoimmunity. During the recent decades, improved socio-economic levels have led to modernized dietary and hygiene approaches that are concomitant with an increased prevalence of autoimmune conditions. This suggests the strong influence of environmental factors on immune modulation. Throughout this review, we discussed how dietary components and hygiene could have diverse implications on immune health and importantly, their implication on immune tolerance and autoimmunity. This includes both direct and indirect effects on immune cell programming. Direct effects are those on cell signaling, cell metabolism and energy intake, and epigenetic modification; and indirect effects include those modulating antioxidant capacities and gut microbiota. The emergence of the COVID-19 pandemic has greatly impacted our dietary and hygiene behaviors. It is thus important to consider the immunomodulatory capacities of environmental factors especially for patients suffering from both COVID-19 and autoimmune disease. Future studies will unravel much-needed mechanistic insights on the immune modulation induced by diet and hygiene and lead to more effective management strategies for autoimmune diseases during emerging threats such as COVID-19. Both authors listed have made a substantial, direct, and intellectual contribution to the work. Preparation of this manuscript was supported by the NIH/ NIAMS under award number R01-AR073240 Basic Concepts in Immunology Resolution of Chronic Inflammatory Disease: Universal and Tissue-Specific Concepts Optimal Immune Responses: Immunocompetence Revisited Overview of the Immune Response The Immune System Evolved to Discriminate Infectious Nonself From Noninfectious Self Not Just Physical Barriers The Role of Epithelial b-Defensins and Cathelicidins in Host Defense of the Lung The Innate Immune Response Approaching the Asymptote? Evolution and Revolution in Immunology Self-Regulation and Cross-Regulation of Pattern-Recognition Receptor Signalling in Health and Disease Innate Immunity: Impact on the Adaptive Immune Response Dendritic Cells: Translating Innate to Adaptive Immunity Both Dendritic Cells and Macrophages Can Stimulate Naive CD8 T Cells In Vivo to Proliferate, Develop Effector Function, and Differentiate Into Memory Cells CD169+ Macrophages Are Sufficient for Priming of CTLs With Specificities Left Out by Cross-Priming Dendritic Cells Neutrophil Recruitment and Function in Health and Inflammation The Interface Between Innate and Adaptive Immunity Antigen-Driven T-Cell Repertoire Selection During Adaptive Immune Responses Antigen-Driven B Cell Differentiation In Vivo Dendritic-Cell Control of Pathogen-Driven T-Cell Polarization Immune Responses: Costimulatory Receptors Have Their Say Self-Tolerance and Its Loss. Immunobiology: The Immune System in Health and Disease Homeostasis and Self-Tolerance in the Immune System: Turning Lymphocytes Off Human Autoimmune Diseases: A Comprehensive Update Breakdown of Self-Tolerance and the Pathogenesis of Autoimmunity T-Cell Tolerance and Autoimmunity in Transgenic Models of Central and Peripheral Tolerance Disturbances of Apoptotic Cell Clearance in Systemic Lupus Erythematosus Apoptosis in SLE-too Little or Too Much? Epidemiology of Systemic Lupus Erythematosus: An Update Epigenetic Regulation and Environmental Factors: Which is the Most Relevant in Developing Autoimmune Diseases? Genetic Susceptibility to Autoimmune Disorders: Clues From Gene Association and Gene Expression Studies Genetic Susceptibility to the Development of Autoimmune Disease Approaches and Advances in the Genetic Causes of Autoimmune Disease and Their Implications Autoimmune Diseases-Connecting Risk Alleles With Molecular Traits of the Immune System Genetic Factors of Autoimmune Diseases The Common Genetic Hypothesis of Autoimmune/ Inflammatory Disease Epidemiology of Environmental Exposures and Human Autoimmune Diseases: Findings From a National Institute of Environmental Health Sciences Expert Panel Workshop Broad Hemagglutinin-Specific Memory B Cell Expansion by Seasonal Influenza Virus Infection Reflects Early-Life Imprinting and Adaptation to the Infecting Virus Infant Complementary Feeding of Prebiotics for the Microbiome and Immunity The Role of Environmental Factors in Modulating Immune Responses in Early Life Immunological Memory. Immunobiology: The Immune System in Health and Disease The World Incidence and Prevalence of Autoimmune Diseases Is Increasing The Hygiene Hypothesis in Autoimmunity: The Role of Pathogens and Commensals The 'Hygiene Hypothesis' for Autoimmune and Allergic Diseases: An Update The Hygiene Hypothesis, Old Friends, and New Genes Role of "Western Diet" in Inflammatory Autoimmune Diseases Digestive Health, and Autoimmunity: The Foundations to an Autoimmune Disease Food Pyramid-Part 1 Diet, Digestive Health, and Autoimmunity: The Foundations to an Autoimmune Disease Food Pyramid-Part 2 Characteristics Associated With Hospitalisation for COVID-19 in People With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician-Reported Registry Autoantibodies Neutralizing Type I IFNs Are Present in~4% of Uninfected Individuals Over 70 Years Old and Account for~20% of COVID-19 Deaths Autoantibodies Against Type I IFNs in Patients With Life-Threatening COVID-19 Association Between Anti-Interferon-Alpha Autoantibodies and COVID-19 in Systemic Lupus Erythematosus Diverse Functional Autoantibodies in Patients With COVID-19 Autoimmunity as the Comet Tail of COVID-19 Pandemic The Triggering of Post-COVID-19 Autoimmunity Phenomena Could be Associated With Both Transient Immunosuppression and an Inappropriate Form of Immune Reconstitution in Susceptible Individuals Could Sars-Coronavirus-2 Trigger Autoimmune and/or Autoinflammatory Mechanisms in Genetically Predisposed Subjects? The Impact of Lockdown During the COVID-19 Outbreak on Dietary Habits in Various Population Groups: A Scoping Review The Potential Impact of Enhanced Hygienic Measures During the COVID-19 Outbreak on Hospital-Acquired Infections: A Pragmatic Study in Neurological Units Pre-Emptive Low Cost Social Distancing and Enhanced Hygiene Implemented Before Local COVID-19 Transmission Could Decrease the Number and Severity of Cases Intestinal Barrier Function and the Gut Microbiome Are Differentially Affected in Mice Fed a Western-Style Diet or Drinking Water Supplemented With Fructose The Role of RAGE in the Pathogenesis of Intestinal Barrier Dysfunction After Hemorrhagic Shock Feeding the Immune System: The Role of Micronutrients in Restoring Resistance to Infections Induction of Gap Junctional Intercellular Communication by Vitamin D in Human Skin Fibroblasts Is Dependent on the Nuclear Vitamin D Receptor Cutting Edge: 1, 25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression Polyunsaturated Fatty Acids on C-Reactive Protein, Interleukin 6 and Tumor Necrosis Factor a: A Meta-Analysis 1 Alpha, 25-Dihydroxyvitamin D3 Inhibits Gamma-Interferon Synthesis by Normal Human Peripheral Blood Lymphocytes Vitamin D Inhibits Monocyte/Macrophage Proinflammatory Cytokine Production by Targeting MAPK Phosphatase-1 All-Trans Retinoic Acid Mediates Enhanced T Reg Cell Growth, Differentiation, and Gut Homing in the Face of High Levels of Co-Stimulation Dietary Folic Acid Promotes Survival of Foxp3+ Regulatory T Cells in the Colon Th17/Treg Imbalance Induced by Dietary Salt Variation Indicates Inflammation of Target Organs in Humans 1, 25-Dihydroxyvitamin D3-Regulated Expression of Genes Involved in Human T-Lymphocyte Proliferation and Differentiation Anti-Inflammatory Effects of the Mediterranean Diet: The Experience of the PREDIMED Study Beneficial Effect of Mediterranean Diet on Disease Activity and Cardiovascular Risk in Systemic Lupus Erythematosus Patients: A Cross-Sectional Study Polyphenols in the Treatment of Autoimmune Diseases Potential Role of Flavonoids in Treating Chronic Inflammatory Diseases With a Special Focus on the Anti-Inflammatory Activity of Apigenin Alleviation of Erythematous Changes in Systemic Lupus Erythematosus (Cutaneous Lupus Erythematosus) With the Use of Flavonoids-Case Study Immunomodulatory Effects of Flavonoids: Possible Induction of T CD4+ Regulatory Cells Through Suppression of mTOR Soy Isoflavones Supplementation Alleviates Disease Severity in Autoimmune-Prone MRL-L p r / L p r M i c e Isoflavone Diet Ameliorates Experimental Autoimmune Encephalomyelitis Through Modulation of Gut Bacteria Depleted in Patients With Multiple Sclerosis Impact of COVID-19 on the Food Supply Chain Plant-Based Diets, Pescatarian Diets and COVID-19 Severity: A Population-Based Case-Control Study in Six Countries Antioxidant Properties of Quercetin Antioxidant and Anti-Inflammatory Activities of Quercetin and Its Derivatives Quercetin as a Potential Treatment for COVID-19-Induced Acute Kidney Injury: Based on Network Pharmacology and Molecular Docking Study Acute Kidney Injury in Patients Hospitalized With COVID-19 COVID-19-Associated Acute Kidney Injury: Consensus Report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup The Effect of Quercetin on Inflammatory Factors and Clinical Symptoms in Women With Rheumatoid Arthritis: A Double-Blind, Randomized Controlled Trial Quercetin Attenuates Zymosan-Induced Arthritis in Mice Quercetin Alleviates Rheumatoid Arthritis by Inhibiting Neutrophil Inflammatory Activities Quercetin Attenuates Collagen-Induced Arthritis by Restoration of Th17/Treg Balance and Activation of Heme Oxygenase 1-Mediated Anti-Inflammatory Effect In Vivo Quercitrin Anti-Inflammatory Effect Involves Release of Quercetin, Which Inhibits Inflammation Through Down-Regulation of the NF-kb Pathway Dietary Quercetin Alleviated DSS-Induced Colitis in Mice Through Several Possible Pathways by Transcriptome Analysis Quercitrin Ameliorates the Development of Systemic Lupus Erythematosus-Like Disease in a Chronic Graft-Versus-Host Murine Model A Review of Micronutrients and the Immune System-Working in Harmony to Reduce the Risk of Infection Antioxidant Vitamins and Their Functions in Immune Responses. Antioxidant Nutrients and Immune Functions Oxidative Stress in Autoimmune Diseases: An Under Dealt Malice Pathological Roles of Oxidative Stress in Autoimmune Diseases Oxidative Stress and Immune System in Vitiligo and Thyroid Diseases Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis Free-Radical and Cyclooxygenase-Catalyzed Lipid Peroxidation in Membranes of Blood Cells Under UV Irradiation T Cell Lipid Peroxidation Induces Ferroptosis and Prevents Immunity to Infection The Role of Phospholipid Oxidation Products in Inflammatory and Autoimmune Diseases Lipid Peroxidation in Systemic Lupus Erythematosus Lipid Peroxidation-Derived Aldehyde-Protein Adducts Contribute to Trichloroethene-Mediated Autoimmunity via Activation of CD4+ T Cells ROS as Signalling Molecules in T Cells-Evidence for Abnormal Redox Signalling in the Autoimmune Disease, Rheumatoid Arthritis Neutrophils and Redox Stress in the Pathogenesis of Autoimmune Disease Oxidative Stress Associated With SARS-Cov-2 (COVID-19) Increases the Severity of the Lung Disease-a Systematic Review Metabolic Implications of Oxidative Stress and Inflammatory Process in SARS-CoV-2 Pathogenesis: Therapeutic Potential of Natural Antioxidants SARS-CoV-2 Infection Pathogenesis is Related to Oxidative Stress as a Response to Aggression The Effect of a-Tocopherol on Monocyte Proatherogenic Activity Is Vitamin E Involved in the Autoimmune Mechanism? The Immunoregulatory Role of Vitamins A, D and E in Patients With Primary Sjögren's Syndrome Cerebellar Syndrome in Adult Celiac Disease With Vitamin E Deficiency Trace Elements and Vitamins at Diagnosis in Pediatric-Onset Inflammatory Bowel Disease Effects and Mechanisms of Vitamin A and Vitamin E on the Levels of Serum Leptin and Other Related Cytokines in Rats With Rheumatoid Arthritis Effect of Allopurinol and Vitamin E on Rat Model of Rheumatoid Arthritis Lupus Erythematosus and Vitamin E: An Effective and Nontoxic Therapy Alternative Therapies: What Role do They Have in the Management of Lupus? The Effects of Vitamin E Supplementation on Autoimmune-Prone New Zealand Black× New Zealand White F1 Mice Fed an Oxidised Oil Diet Stress in Systemic Lupus Erythematosus: Relationship to Disease Activity and Symptoms Oxidative Stress in Systemic Lupus Erythematosus: Relationship to Th1 Cytokine and Disease Activity Effect of Nigella Sativa and Vitamin E on Some Oxidative/Nitrosative Biomarkers in Systemic Lupus Erythematosus Patients 25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation Inhibition of IL-12 Production by 1, 25-Dihydroxyvitamin D3. Involvement of NF-kappaB Downregulation in Transcriptional Repression of the P40 Gene Dendritic Cell Tolerogenicity: A Key Mechanism in Immunomodulation by Vitamin D Receptor Agonists Vitamin D3 Induces Tolerance in Human Dendritic Cells by Activation of Intracellular Metabolic Pathways Vitamin A Rewrites the ABCs of Oral Tolerance Retinoids Regulate Survival and Antigen Presentation by Immature Dendritic Cells Retinoic Acid Decreases Adherence of Murine Myeloid Dendritic Cells and Increases Production of Matrix Metalloproteinase-9 Breakdown of Immune Tolerance in Systemic Lupus Erythematosus by Dendritic Cells Regulation of Dendritic Cell Function by Vitamin D Vitamin A and Immune Regulation: Role of Retinoic Acid in Gut-Associated Dendritic Cell Education, Immune Protection and Tolerance Retinoic Acid-Dependent Regulation of Immune Responses by Dendritic Cells and Macrophages Immunoregulation by 1, 25-Dihydroxyvitamin D3: Basic Concepts Immunosuppressive Actions of 1, 25-Dihydroxyvitamin D3: Preferential Inhibition of Th1 Functions Vitamin D3: A Transcriptional Modulator of the Interferon-g Gene Vitamin A Enhances In Vitro Th2 Development via Retinoid X Receptor Pathway Twisting the Th1/Th2 Immune Response via the Retinoid X Receptor: Lessons From a Genetic Approach Retinoic Acids Exert Direct Effects on T Cells to Suppress Th1 Development and Enhance Th2 Development via Retinoic Acid Receptors 1,25-Dihyroxyvitamin D3 Promotes FOXP3 Expression via Binding to Vitamin D Response Elements in Its Conserved Noncoding Sequence Region Vitamin D Improves Cognitive Function and Modulates T H 17/T Reg Cell Balance After Hepatectomy in Mice Regulation of FoxP 3+ Regulatory T Cells and Th17 Cells by Retinoids Signal Transduction Pathways and Transcriptional Regulation in the Control of Th17 Differentiation All-Trans Retinoic Acid Promotes TGF-b-Induced Tregs via Histone Modification But Not DNA Demethylation on Foxp3 Gene Locus The Role of the T Cell in Autoimmune Inflammation Imbalance of Regulatory T Cells in Human Autoimmune Diseases Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention Explaining Multiple Sclerosis Prevalence by Ultraviolet Exposure: A Geospatial Analysis Ultraviolet Radiation and Autoimmune Disease: Insights From Epidemiological Research Vitamin D Receptor Gene Polymorphism is Associated With Graves' Disease in the Japanese Population Vitamin D Receptor Gene Polymorphisms in Hashimoto's Thyroiditis Family-Based Analysis of Vitamin D Receptor Gene Polymorphisms and Type 1 Diabetes in the Population of South Croatia Association of Vitamin D Receptor Gene Polymorphism With Multiple Sclerosis in Japanese Association Study of VDR Gene With Rheumatoid Arthritis in the French Population Vitamin D Receptor Gene BsmI Polymorphisms in Thai Patients With Systemic Lupus Erythematosus Hypovitaminosis D is Associated With Greater Body Mass Index and Disease Activity in Pediatric Systemic Lupus Erythematosus Vitamin D Deficiency in Patients With Active Systemic Lupus Erythematosus Vitamin D Deficiency in Systemic Lupus Erythematosus Association of Low Vitamin D With High Disease Activity in an Australian Systemic Lupus Erythematosus Cohort Low Levels of Vitamin D Promote Memory B Cells in Lupus Vitamin D Deficiency Is Associated With an Increased Autoimmune Response in Healthy Individuals and in Patients With Systemic Lupus Erythematosus Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential 25-Hydroxyvitamin D Concentrations Are Lower in Patients With Positive PCR for SARS-CoV-2 Serum Levels of Vitamin C and Vitamin D in a Cohort of Critically Ill COVID-19 Patients of a North American Community Hospital Intensive Care Unit in May 2020: A Pilot Study Vitamin D and Survival in COVID-19 Patients: A Quasi-Experimental Study Vitamin A: Yet Another Player in Multiple Sclerosis Pathogenesis? Serum Concentrations of a Tocopherol, b Carotene, and Retinol Preceding the Diagnosis of Rheumatoid Arthritis and Systemic Lupus Erythematosus Vitamin D Receptor Gene BsmI Polymorphisms in Egyptian Children and Adolescents With Systemic Lupus Erythematosus: A Case-Control Study Retinoic Acid, Leaky Gut, and Autoimmune Diseases Paradoxical Effects of All-Trans-Retinoic Acid on Lupus-Like Disease in the MRL/lpr Mouse Model Vitamin A Improve Th17 and Treg Regulation in Systemic Lupus Erythematosus COVID-19: Endogenous Retinoic Acid Theory and Retinoic Acid Depletion Syndrome Mega Doses of Retinol: A Possible Immunomodulation in Covid-19 Illness in Resource-Limited Settings Essential Trace Elements in Antioxidant Processes Trace Elements as an Activator of Antioxidant Enzymes The Role of Vitamins and Minerals in Energy Metabolism and Well-Being Trace Elements in Regulation of NF-kb Activity Intracellular Zinc Fluctuations Modulate Protein Tyrosine Phosphatase Activity in Insulin/Insulin-Like Growth Factor-1 Zinc Protects Against Cadmium-Induced Toxicity by Regulating Oxidative Stress, Ions Homeostasis and Protein Synthesis Effects of Zinc Deficiency on Protein Synthesis and Expression of Specific mRNAs in Rat Liver The Biological Role and Antioxidant Activity Biochemical Role as a Component of Glutathione Peroxidase Effects of Dietary Selenium and Vitamin E on Red Blood Cell Peroxidation, Glutathione Peroxidase Activity, and Macrophage Superoxide Anion Production in Channel Catfish Effect of Polysaccharide Krestin on Glutathione Peroxidase Gene Expression in Mouse Peritoneal Macrophages Role of Selenium-Dependent Glutathione Peroxidase in Antioxidant Defenses in Rat Alveolar Macrophages Lymphocyte and Chronic Inflammatory Responses in Selenium Deficient Rodents. Association With Decreased Glutathione Peroxidase Activity Selenium and Inflammation: Underlying Anti-Inflammatory Mechanisms Selenium Deficiency in Celiac Disease: Risk of Autoimmune Thyroid Diseases Genetically Determined Selenium Concentrations and Risk for Autoimmune Diseases Improved Survival in Murine Lupus as the Result of Selenium Supplementation Selenium Supplementation Suppresses Immunological and Serological Features of Lupus in B6. Sle1b Mice Selenium Deficiency is Associated With Mortality Risk From COVID-19 Zinc and Immunity: An Essential Interrelation Regulation and Function of NF-Kappab Signal Transduction in Monocytes: The Role of Zinc Ions Metal Ions in Macrophage Antimicrobial Pathways: Emerging Roles for Zinc and Copper Zinc Requirement for Macrophage Function: Effect of Zinc Deficiency on Uptake and Killing of a Protozoan Parasite Serum Levels of Copper and Zinc in Patients With Rheumatoid Arthritis: A Meta-Analysis Zinc Induces Dendritic Cell Tolerogenic Phenotype and Skews Regulatory T Cell-Th17 Balance Zinc Signals Promote IL-2-Dependent Proliferation of T Cells Role of Zinc in Interleukin 2 (IL-2)-Mediated T-Cell Activation Intracellular Free Zinc Up-Regulates IFN-g and T-Bet Essential for Th1 Differentiation in Con-A Stimulated HUT-78 Cells Effects of Zinc Deficiency on Th1 and Th2 Cytokine Shifts Zinc Supplementation Induces CD4+ CD25+ Foxp3+ Antigen-Specific Regulatory T Cells and Suppresses IFN-g Production by Upregulation of Foxp3 and KLF-10 and Downregulation of IRF-1 Zinc Suppresses Th17 Development via Inhibition of STAT3 Activation Inhibition of Interleukin-1b-Mediated Interleukin-1 Receptor-Associated Kinase 4 Phosphorylation by Zinc Leads to Repression of Memory T Helper Type 17 Response in Humans Induction of Regulatory T Cells in Th1-/Th17-Driven Experimental Autoimmune Encephalomyelitis by Zinc Administration Zinc Aspartate Suppresses T Cell Activation In Vitro and Relapsing Experimental Autoimmune Encephalomyelitis in SJL/J Mice Zinc Status and Autoimmunity: A Systematic Review and Meta-Analysis Lower Serum Zinc Levels in Patients With Multiple Sclerosis Compared to Healthy Controls Trace Elements and Some Extracellular Antioxidant Proteins Levels in Serum of Patients With Systemic Lupus Erythematosus Association Between Serum Trace Element Concentrations and the Disease Activity of Systemic Lupus Erythematosus COVID-19: Poor Outcomes in Patients With Zinc Deficiency Fat-Soluble Vitamins and the Current Global Pandemic of COVID-19: Evidence-Based Efficacy From Literature Review Nutritional Status of Micronutrients as a Possible and Modifiable Risk Factor for COVID-19: A UK Perspective Micronutrient Status of COVID-19 Patients: A Critical Consideration Contribution of Macronutrients to Obesity: Implications for Precision Nutrition Individuals With Obesity and COVID-19: A Global Perspective on the Epidemiology and Biological Relationships Obesity and COVID-19 in New York City: A Retrospective Cohort Study The Impact of Obesity on COVID-19 Complications: A Retrospective Cohort Study Carbohydrates in Food Immunomodulation by Food: Impact on Gut Immunity and Immune Cell Function The Role of Gut Microbiota in Immune Homeostasis and Autoimmunity Effects of Prebiotics on Immune System and Cytokine Expression Medicinal Importance of Fungal b-(1! 3),(1! 6)-Glucans The Immunobiology of Mushrooms Metabolic Regulation of Immune Responses Inflammatory Mechanisms Linking Obesity and Metabolic Disease Inflammation and Metabolic Disorders High Glucose Intake Exacerbates Autoimmunity Through Reactive-Oxygen-Species-Mediated TGF-b Cytokine Activation Diet and Nutritional Aspects in Systemic Lupus Erythematosus Dietary Non-Fermentable Fiber Prevents Autoimmune Neurological Disease by Changing Gut Metabolic and Immune Status Phytosterols: Targeting Neuroinflammation in Neurodegeneration Phytosterols Ameliorate Clinical Manifestations and Inflammation in Experimental Autoimmune Encephalomyelitis Dietary Supplementation With N-3 Fatty Acids Suppresses Interleukin-2 Production and Mononuclear Cell Proliferation Short-Term Consumption of a High-Fat Diet Increases Host Susceptibility to Listeria Monocytogenes Infection Ketogenic Diet Activates Protective gd T Cell Responses Against Influenza Virus Infection Dietary Lipids and Risk of Autoimmune Disease Dietary Fat and Immune Function. I. Antibody Responses, Lymphocyte and Accessory Cell Function in (NZB X NZW) F1 Mice Lupus Autoimmunity and Metabolic Parameters Are Exacerbated Upon High Fat Diet-Induced Obesity Due to TLR7 Signaling Lupus Pathogenesis and Autoimmunity Are Exacerbated by High Fat Diet-Induced Obesity in Mice Dietary Fish Oil and the Severity of Symptoms in Patients With Systemic Lupus Erythematosus Reduced Mass and Diversity of the Colonic Microbiome in Patients With Multiple Sclerosis and Their Improvement With Ketogenic Diet Type 1 Diabetes Mellitus Successfully Managed With the Paleolithic Ketogenic Diet Ketogenic Diet as a Preventive and Supportive Care for COVID-19 Patients Clinical Efficacy of Eucaloric Ketogenic Nutrition in the COVID-19 Cytokine Storm: A Retrospective Analysis of Mortality and Intensive Care Unit Admission Contribution of Dietary Intake to Relapse Rate in Early Paediatric Multiple Sclerosis A Pilot Study of a Mediterranean-Type Diet Intervention in Female Patients With Rheumatoid Arthritis Living in Areas of Social Deprivation in Glasgow Healthy Lifestyle Habits for Patients With Systemic Lupus Erythematosus: A Systemic Review Negative Association Between Mediterranean Diet Adherence and COVID-19 Cases and Related Deaths in Spain and 25 OECD Countries: An Ecological Study Mediterranean Diet as a Nutritional Approach for COVID-19 Phytochemicals and Mediterranean Diet: A Potential Protective Role Against COVID-19 Through Modulation of PAF Actions and Metabolism The Type of Dietary Fat Affects the Severity of Autoimmune Disease in NZB/NZW Mice Life Span is Prolonged in Food-Restricted Autoimmune-Prone (NZB× NZW) F (1) Mice Fed a Diet Enriched With (N-3) Fatty Acids Decreased Proinflammatory Cytokines and Increased Antioxidant Enzyme Gene Expression by w-3 Lipids in Murine Lupus Nephritis Dietary Omega-3 Lipids Delay the Onset and Progression of Autoimmune Lupus Nephritis by Inhibiting Transforming Growth Factor b mRNA and Protein Expression Requisite Omega-3 HUFA Biomarker Thresholds for Preventing Murine Lupus Flaring Dietary Omega-3 Polyunsaturated Fatty Acids Reduce IFN-Gamma Receptor Expression in Mice Comparative Effects of N-3, N-6 and N-9 Unsaturated Fatty Acid-Rich Diet Consumption on Lupus Nephritis, Autoantibody Production and CD4+ T Cell-Related Gene Responses in the Autoimmune NZBWF1 Mouse Dietary N-3 PUFA May Attenuate Experimental Colitis Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the COVID-Omega-F Trial Omega-3 Fatty Acids in the Psychological and Physiological Resilience Against COVID-19 Blood Omega-3 Fatty Acids and Death From COVID-19: A Pilot Study Amino Acids and Immune Function Dietary Protein and Gut Microbiota Composition and Function Stimulation by Food Proteins Plays a Critical Role in the Maturation of the Immune System Antigenic Dietary Protein Guides Maturation of the Host Immune System Promoting Resistance to Leishmania Major Infection Effect of a Protein-Free Diet in the Development of Food Allergy and Oral Tolerance in BALB/c Mice Oral Tolerance to Food Protein Immunoglobulin Production is Impaired in Protein-Deprived Mice and Can be Restored by Dietary Protein Supplementation Protein Malnutrition Predisposes to Inflammatory-Induced Gut-Origin Septic States Influence of Plant and Animal Proteins on Inflammation Markers Among Adults With Chronic Kidney Disease: A Systematic Review and Meta-Analysis Diet Rich in Animal Protein Promotes Pro-Inflammatory Macrophage Response and Exacerbates Colitis in Mice Eleven Reasons to Control the Protein Intake of Patients With Chronic Kidney Disease Dietary Protein Intake and Chronic Kidney Disease The Role of Balanced Low-Protein Diet in Inhibition of Progression of Predialysis Chronic Disease of the Kidneys in Systemic Diseases Influence of Protein Restriction on Immune Functions in NZB Mice Obesity and Susceptibility to Autoimmune Diseases Excess Calorie Intake Early in Life Increases Susceptibility to Colitis in Adulthood The Association of Obesity With Autoimmune Thyroiditis and Thyroid Function-Possible Mechanisms of Bilateral Interaction Effects of Calorie Restriction on Immunologic Functions and Development of Autoimmune Disease in NZB Mice Decrease by Chronic Energy Intake Restriction of Cellular Proliferation in the Intestinal Epithelium and Lymphoid Organs in Autoimmunity-Prone Mice Calorie Restriction Decreases Proinflammatory Cytokines and Polymeric Ig Receptor Expression in the Submandibular Glands of Autoimmune Prone (NZB× NZW) F1 Mice Calorie Restriction Decreases Platelet-Derived Growth Factor (PDGF)-A and Thrombin Receptor mRNA Expression in Autoimmune Murine Lupus Nephritis Calorie Restriction Prevents the Occlusive Coronary Vascular Disease of Autoimmune (NZW X BXSB) F1 Mice Regulation of Immune Function by Calorie Restriction and Cyclophosphamide Treatment in Lupus-Prone NZB/NZW F1 Mice Chronic Calorie Restriction Attenuates Experimental Autoimmune Encephalomyelitis Intermittent Feeding Attenuates Clinical Course of Experimental Autoimmune Encephalomyelitis in C57BL/6 Mice Intermittent Caloric Restriction With a Modified Fasting-Mimicking Diet Ameliorates Autoimmunity and Promotes Recovery in a Mouse Model of Multiple Sclerosis Calorie Restriction Promotes Remyelination in a Cuprizone-Induced Demyelination Mouse Model of Multiple Sclerosis Effects of Calorie Restriction on Transforming Growth Factor b1 and Proinflammatory Cytokines in Murine Sjogren's Syndrome A Guide to Immunometabolism for Immunologists Immunometabolism: Cellular Metabolism Turns Immune Regulator T Cell Metabolism Drives Immunity Metabolic Regulation of Macrophage Phenotype and Function Metabolic Regulation of T Lymphocytes Characterization of the Metabolic Phenotype of Chronically Activated Lymphocytes Obesity Predisposes to Th17 Bias The PI-3 Kinase/Akt Pathway and T Cell Activation: Pleiotropic Pathways Downstream of PIP3 The Role of the PI3K Signaling Pathway in CD4+ T Cell Differentiation and Function CD28 Provides T-Cell Costimulation and Enhances PI3K Activity at the Immune Synapse Independently of Its Capacity to Interact With the P85/P110 A Complex Interplay Between Akt, TSC2 and the Two mTOR Complexes The Mammalian Target of Rapamycin: Linking T Cell Differentiation, Function, and Metabolism mTOR Regulates T-Cell Differentiation and Activation in Immunity and Autoimmunity mTOR Regulation of Lymphoid Cells in Immunity to Pathogens Activation of mTOR (Mechanistic Target of Rapamycin) in Rheumatic Diseases Mechanistic Target of Rapamycin Complex 1 Expands Th17 and IL-4+ CD4-CD8-Double-Negative T Cells and Contracts Regulatory T Cells in Systemic Lupus Erythematosus Lupus-Associated Atypical Memory B Cells Are Mtorc1-Hyperactivated and Functionally Dysregulated High-Throughput Compound Screen Reveals mTOR Inhibitors as Potential Therapeutics to Reduce (Auto) Antibody Production by Human Plasma Cells Cell-Intrinsic Mtorc1 Promotes Germinal Center-Defining Transcription Factor Gene Expression, Somatic Hypermutation, and Memory B Cell Generation in Humoral Immunity Regulation of Dendritic Cell Immune Function and Metabolism by Cellular Nutrient Sensor Mammalian Target of Rapamycin (mTOR) Immune Responses of Macrophages and Dendritic Cells Regulated by mTOR Signalling Mitochondrial Hyperpolarization and ATP Depletion in Patients With Systemic Lupus Erythematosus Cellular and Metabolic Requirements of Effector T Cells mTOR Couples Cellular Nutrient Sensing to Organismal Metabolic Homeostasis Nutrient Signaling to mTOR and Cell Growth Leptin-Induced mTOR Activation Defines a Specific Molecular and Transcriptional Signature Controlling CD4+ Effector T Cell Responses Targeting T Cell Metabolism for Therapy Novel Therapeutic Strategy for Cancer and Autoimmune Conditions: Modulating Cell Metabolism and Redox Capacity Suppression of Cellular and Humoral Immunity to T-Dependent Antigens by Calorie Restriction Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool Inhibition by Restricted-Calorie Diet of Lymphoproliferative Disease and Renal Damage in MRL/lpr Mice Calorie Restriction Modulates Lymphocyte Subset Phenotype and Increases Apoptosis in MRLlpr Mice C van Kooten and FJ Dor eds. Dietary Restriction and Fasting Downregulate Complement Activity Immune Dysfunction as a Cause and Consequence of Malnutrition Long-Term Effects of Malnutrition on Severity of COVID-19 The Burden of Malnutrition and Fatal COVID-19: A Global Burden of Disease Analysis Nutritional Management of COVID-19 Patients in a Rehabilitation Unit The Efficacy of Vitamin E Against Oxidative Damage and Autoantibody Production in Systemic Lupus Erythematosus: A Preliminary Study Brief Report: Vitamin D Deficiency Is Associated With Endothelial Dysfunction and Increases Type I Interferon Gene Expression in a Murine Model of Systemic Lupus Erythematosus Role of Vitamin D/VDR Nuclear Translocation in Down-Regulation of NF Axis in Lupus Nephritis Vitamin D Deficiency in Patients With Systemic Lupus Erythematosus Vitamin D Status in Systemic Lupus Erythematosus Patients and Its Association With Selected Clinical and Laboratory Parameters Dietary Omega Polyunsaturated Fatty Acid Intake and Patient-Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program Postnatal Innate Immune Development: From Birth to Adulthood Neonatal Adaptive Immunity Comes of Age The Ability of B Cells and Dendritic Cells to Present Antigen Increases During Ontogeny Phagocytic Ability of Neutrophils and Monocytes in Neonates Default" Generation of Neonatal Regulatory T Cells Unbalanced Neonatal CD4+ T-Cell Immunity Decreased Production of Interferon-Gamma by Human Neonatal Cells. Intrinsic and Regulatory Deficiencies The Control of Adaptive Immune Responses by the Innate Immune System Impact of Early-Life Exposures on Immune Maturation and Susceptibility to Disease Gut Immune Maturation Depends on Colonization With a Host-Specific Microbiota The Commensal Microbiota Drives Immune Homeostasis Microbiota-Activated PPAR-g Signaling Inhibits Dysbiotic Enterobacteriaceae Expansion The Human Microbiota in Health and Disease Lung Microbiota Promotes Tolerance to Allergens in Neonates via PD-L1 Dysregulation of Allergic Airway Inflammation in the Absence of Microbial Colonization Influence of Antibiotic Exposure in the Early Postnatal Period on the Development of Intestinal Microbiota Prenatal and Early-Life Exposures Alter Expression of Innate Immunity Genes: The PASTURE Cohort Study Intestinal Microbial Diversity During Early-Life Colonization Shapes Long-Term IgE Levels Life at the Beginning: Perturbation of the Microbiota by Antibiotics in Early Life and Its Role in Health and Disease Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19 SARS-CoV-2-Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children Coagulopathy and Antiphospholipid Antibodies in Patients With Covid-19 Concomitant New Diagnosis of Systemic Lupus Erythematosus and COVID-19 With Possible Antiphospholipid Syndrome. Just a Coincidence? A Case Report and Review of Intertwining Pathophysiology Autoimmune Haemolytic Anaemia Associated With COVID-19 Infection SARS-CoV-2 Can Induce Brain and Spine Demyelinating Lesions Autoimmune and Inflammatory Diseases Following COVID-19 Mechanisms for the Induction of Autoimmunity by Infectious Agents Infections and Autoimmune Diseases Possible Triggering Effect of Cytomegalovirus Infection on Systemic Lupus Erythematosus Exacerbation of Systemic Lupus Erythematosus Related to Cytomegalovirus Infection An Increased Prevalence of Epstein-Barr Virus Infection in Young Patients Suggests a Possible Etiology for Systemic Lupus Erythematosus Expression of the Epstein-Barr Virus Nuclear Antigen-1 (EBNA-1) in the Mouse Can Elicit the Production of anti-dsDNA and Anti-Sm Antibodies Current Mechanistic Insights Into the Role of Infection in Systemic Lupus Erythematosus Cytokine Storms, Hyper-Inflammatory Phenotypes, and Acute Respiratory Distress Syndrome Antibody to Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus Spike Protein Domain 2 Cross-Reacts With Lung Epithelial Cells and Causes Cytotoxicity COVID-19 as a Trigger of Brain Autoimmunity Suppression of Autoimmune Disease in NZB and (NZB× NZW) F 1 Hybrid Mice by Infection With Malaria Immunoregulation of CNS Autoimmunity by Helminth and Mycobacterial Infections Prevention of Type I Diabetes in Nonobese Diabetic Mice by Virus Infection Antigenic Competition: A Review of Nonspecific Antigen-Induced Suppression Endotoxin Tolerance Inhibits Lyn and C-Src Phosphorylation and Association With Toll-Like Receptor 4 But Increases Expression and Activity of Protein Phosphatases Inhibition of Lipopolysaccharide-Induced Signal Transduction in Endotoxin-Tolerized Mouse Macrophages: Dysregulation of Cytokine, Chemokine, and Toll-Like Receptor 2 and 4 Gene Expression Inhibition of Autoimmune Diabetes by TLR2 Tolerance TLR Tolerance as a Treatment for Central Nervous System Autoimmunity Type I IFN Signaling Constrains IL-17a/F Secretion by gd T Cells During Bacterial Infections Environmental Agents and Autoimmune Diseases Factors Influencing the Development of a Personal Tailored Microbiota in the Neonate, With Particular Emphasis on Antibiotic Therapy Probiotics to Minimize the Disruption of Faecal Microbiota in Healthy Subjects Undergoing Antibiotic Therapy Antibiotic-Induced Gut Microbiota Disruption During Human Endotoxemia: A Randomised Controlled Study Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice Decreased Bacterial Diversity Characterizes the Altered Gut Microbiota in Patients With Psoriatic Arthritis, Resembling Dysbiosis in Inflammatory Bowel Disease Analysis of Endoscopic Brush Samples Identified Mucosa-Associated Dysbiosis in Inflammatory Bowel Disease Alterations of the Gut Microbiome in Chinese Patients With Systemic Lupus Erythematosus Gut Microbiota in Human Systemic Lupus Erythematosus and a Mouse Model of Lupus The Gut Microbiota: A Possible Factor Influencing Systemic Lupus Erythematosus Alteration in Gut Microbiota Is Associated With Dysregulation of Cytokines and Glucocorticoid Therapy in Systemic Lupus Erythematosus Dysbiosis of Oral Microbiota Is Associated With Systemic Lupus Erythematosus The Impact of COVID-19 Pandemic on Hand Hygiene Performance in Hospitals Public Perception and Hand Hygiene Behavior During COVID-19 Pandemic in Indonesia Changes in Handwashing and Hygiene Product Usage Patterns in Korea Before and After the Outbreak of COVID-19 The Hygiene Hypothesis, the COVID Pandemic, and Consequences for the Human Microbiome The Most Important Challenges Ahead of Microbiome Pattern in the Post Era of the COVID-19 Gut Microbiota Composition Reflects Disease Severity and Dysfunctional Immune Responses in Patients With COVID-19 Metagenomic and Metabolomic Analysis of the Toxic Effects of Trichloroacetamide-Induced Gut Microbiome and Urine Metabolome Perturbations in Mice Gut Microbiota in Children With Type 1 Diabetes Differs From That in Healthy Children: A Case-Control Study The Role of Bacteria and Pattern-Recognition Receptors in Crohn's Disease Intestinal Dysbiosis Associated With Systemic Lupus Erythematosus Profound Perturbation Induced by Triclosan Exposure in Mouse Gut Microbiome: A Less Resilient Microbial Community With Elevated Antibiotic and Metal Resistomes Triclosan Enhances the Clearing of Pathogenic Intracellular Salmonella or Candida Albicans But Disturbs the Intestinal Microbiota Through mTOR-Independent Autophagy Perturbation and Restoration of the Fathead Minnow Gut Microbiome After Low-Level Triclosan Exposure Effects of Triclosan in Breast Milk on the Infant Fecal Microbiome Postnatal Exposure to Household Disinfectants, Infant Gut Microbiota and Subsequent Risk of Overweight in Children Dynamics of Gut Microbiota in Autoimmune Lupus Antiseptics and Disinfectants: Activity, Action, and Resistance Evaluating Immunotoxicity of Quaternary Ammonium Compounds. Virginia Tech Electronic Theses and Dissertations (ETDs The Role of Defective Clearance of Apoptotic Cells in Systemic Autoimmunity The Role of Efferocytosis in Autoimmune Diseases Quaternary Ammonium Compound Disinfectants Reduce Lupus-Associated Splenomegaly by Targeting Neutrophil Migration and T-Cell Fate DNA Methylation Levels and Long-Term Trihalomethane Exposure in Drinking Water: An Epigenome-Wide Association Study Epigenetic Control of T-Helper-Cell Differentiation DNA Methylation and Autoimmune Disease The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.